On 19 Nov 2025, Asarfi Hospital's stock price touched an intraday high of Rs.221, representing an 8.23% increase during the trading session. The stock opened with a gap up of 4.8%, signalling strong buying interest from the outset. This price level also marks the highest ever recorded for the company, surpassing previous peaks and setting a fresh benchmark for investors and market watchers.
The stock has demonstrated consistent upward movement, registering gains for four consecutive days. Over this period, Asarfi Hospital has delivered a cumulative return of 33.8%, significantly outperforming its hospital sector peers by 7% on the day of the new high. This sustained rally has been supported by the stock trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a robust technical trend.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- Current monthly selection
- Single best opportunity
- Elite universe pick
From a broader market perspective, the Sensex opened flat but gained momentum to close at 85,027.46 points, up 0.42% or 383.68 points. The index remains close to its own 52-week high of 85,290.06, trading just 0.31% below that level. Mega-cap stocks led the market rally, with the Sensex trading above its 50-day moving average, which itself is positioned above the 200-day moving average, signalling a bullish market environment.
Asarfi Hospital’s market capitalisation grade stands at 4, reflecting its position within the hospital sector and broader market. The company’s Mojo Score is 77.0, with a recent adjustment in its evaluation noted on 14 Nov 2025. This score reflects various financial and market factors that contribute to the stock’s current standing.
Financially, Asarfi Hospital has reported net sales of Rs.44.89 crores in the latest quarter, the highest quarterly figure recorded by the company. Profit before depreciation, interest, and tax (PBDIT) reached Rs.8.87 crores, while profit before tax excluding other income stood at Rs.4.89 crores, both representing peak quarterly performances. The company’s net profit growth for the period was 34.38%, with positive results declared for two consecutive quarters.
Over the past year, Asarfi Hospital’s stock has generated a return of 150.14%, significantly outpacing the Sensex’s 9.60% return over the same period. This market-beating performance is accompanied by a profit rise of 161% during the year, with the company’s PEG ratio at 0.2, indicating valuation metrics relative to earnings growth.
Asarfi Hospital caught your attention? Explore our comprehensive research report with in-depth analysis of this micro-cap Hospital stock – fundamentals, valuations, financials, and technical outlook!
- Comprehensive research report
- In-depth micro-cap analysis
- Valuation assessment included
Despite the strong price performance, certain financial metrics suggest areas of caution. The company’s return on capital employed (ROCE) is recorded at 8.67%, indicating modest profitability per unit of capital invested. Additionally, operating profit has grown at an annual rate of 14.76% over the past five years, reflecting steady but moderate long-term growth.
Institutional investor participation has seen a decline, with a reduction of 1.04% in their stake over the previous quarter. Currently, institutional investors hold 2.24% of the company’s shares. This shift in shareholding patterns may influence market dynamics and liquidity considerations.
Asarfi Hospital’s debt servicing capability is reflected in a low Debt to EBITDA ratio of 1.44 times, suggesting manageable leverage levels relative to earnings before interest, tax, depreciation, and amortisation. The company’s enterprise value to capital employed ratio stands at 3.4, which may be considered attractive in valuation terms within the hospital sector.
The stock’s 52-week low price was Rs.72.9, highlighting the substantial price appreciation to the current high of Rs.221. This wide price range over the year underscores the stock’s volatility and the momentum it has gained in recent months.
In summary, Asarfi Hospital’s achievement of a new 52-week high at Rs.221 is supported by strong quarterly financials, sustained price momentum, and favourable technical indicators. The stock’s performance has notably outpaced the broader market and sector indices, reflecting a period of significant value realisation for the company.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
